Analysen zu Novo Nordisk
| 29.04.24 | Novo Nordisk Neutral | UBS AG | |
| 25.04.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | Novo Nordisk Outperform | Bernstein Research | |
| 26.03.24 | Novo Nordisk Neutral | UBS AG | |
| 25.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 18.03.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 11.03.24 | Novo Nordisk Neutral | UBS AG | |
| 08.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 06.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.03.24 | Novo Nordisk Neutral | UBS AG | |
| 01.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.02.24 | Novo Nordisk Neutral | UBS AG | |
| 27.02.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 14.02.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 05.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Novo Nordisk Halten | DZ BANK | |
| 01.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 01.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 31.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Novo Nordisk Neutral | UBS AG | |
| 31.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 30.01.24 | Novo Nordisk Neutral | UBS AG | |
| 24.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.24 | Novo Nordisk Overweight | Barclays Capital | |
| 16.01.24 | Novo Nordisk Buy | Jefferies & Company Inc. | |
| 15.01.24 | Novo Nordisk Neutral | UBS AG | |
| 12.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.12.23 | Novo Nordisk Overweight | Barclays Capital | |
| 15.12.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 08.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.12.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 15.04.25 | ING Group Buy | UBS AG | |
| 15.04.25 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
| 15.04.25 | VINCI Buy | Jefferies & Company Inc. | |
| 15.04.25 | Sixt Buy | Baader Bank | |
| 15.04.25 | AXA Overweight | JP Morgan Chase & Co. | |
| 15.04.25 | Givaudan Halten | DZ BANK | |
| 15.04.25 | PVA TePla Buy | Jefferies & Company Inc. | |
| 15.04.25 | Boeing Outperform | RBC Capital Markets | |
| 15.04.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 15.04.25 | L'Oréal Underweight | JP Morgan Chase & Co. | |
| 15.04.25 | L'Oréal Neutral | UBS AG | |
| 15.04.25 | Boeing Overweight | JP Morgan Chase & Co. | |
| 15.04.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 15.04.25 | Glencore Buy | UBS AG | |
| 15.04.25 | Rio Tinto Neutral | UBS AG | |
| 15.04.25 | Stellantis Hold | Deutsche Bank AG | |
| 15.04.25 | Vodafone Group Neutral | UBS AG | |
| 15.04.25 | DocMorris Hold | Deutsche Bank AG | |
| 15.04.25 | SAFRAN Buy | Deutsche Bank AG | |
| 15.04.25 | Netflix Outperform | Bernstein Research | |
| 15.04.25 | RATIONAL Reduce | Baader Bank | |
| 15.04.25 | Beiersdorf Outperform | Bernstein Research | |
| 15.04.25 | BNP Paribas Buy | Deutsche Bank AG | |
| 15.04.25 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 15.04.25 | TotalEnergies Outperform | RBC Capital Markets | |
| 15.04.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 15.04.25 | Intel Underweight | JP Morgan Chase & Co. | |
| 15.04.25 | STMicroelectronics Neutral | JP Morgan Chase & Co. | |
| 15.04.25 | Infineon Neutral | JP Morgan Chase & Co. | |
| 15.04.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 15.04.25 | National Grid Overweight | JP Morgan Chase & Co. | |
| 15.04.25 | Beiersdorf Sell | Deutsche Bank AG | |
| 15.04.25 | Beiersdorf Sector Perform | RBC Capital Markets | |
| 15.04.25 | Microsoft Buy | Jefferies & Company Inc. | |
| 15.04.25 | Alphabet A Buy | Jefferies & Company Inc. | |
| 15.04.25 | Netflix Buy | Jefferies & Company Inc. | |
| 15.04.25 | Amazon Buy | Jefferies & Company Inc. | |
| 15.04.25 | TotalEnergies Hold | Jefferies & Company Inc. | |
| 15.04.25 | ArcelorMittal Hold | Jefferies & Company Inc. | |
| 15.04.25 | National Grid Buy | Jefferies & Company Inc. | |
| 15.04.25 | Iberdrola Buy | Jefferies & Company Inc. | |
| 15.04.25 | RWE Buy | Jefferies & Company Inc. | |
| 15.04.25 | Enel Buy | Jefferies & Company Inc. | |
| 15.04.25 | E.ON Hold | Jefferies & Company Inc. | |
| 15.04.25 | SAF-HOLLAND Hold | Deutsche Bank AG | |
| 15.04.25 | National Grid Buy | UBS AG | |
| 15.04.25 | Iberdrola Buy | UBS AG | |
| 15.04.25 | E.ON Buy | UBS AG | |
| 15.04.25 | TotalEnergies Buy | UBS AG | |
| 15.04.25 | Ericsson Sell | UBS AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.